FASLODEX (FULVESTRANT)

250 mg/5 mL intramuscular syringe

• Inject 10 milliliters (500 mg) as 2 equally divided injections, one in each buttock, over 1-2 minute(s) by intramuscular route once a month

250 mg/5 mL intramuscular syringe

• Inject 10 milliliters (500 mg) as 2 equally divided injections, one in each buttock, over 1-2 minute(s) by intramuscular route once a month

Hormone receptor + postmenopausal advanced breast cancer

• Inject 10 milliliters (500 mg) as 2 equally divided injections, one into each buttock, over 1-2 minute(s) by intramuscular route every 14 days for 3 doses

• Inject 10 milliliters (500 mg) as 2 equally divided injections, one into each buttock, over 1-2 minute(s) by intramuscular route once a month

• Inject 10 milliliters (500 mg) as 2 equally divided injections, one in each buttock, over 1-2 minute(s) by intramuscular route once a month

Hr(+), HEr2(-) advanced female breast cancer

• Inject 10 milliliters (500 mg) as 2 equally divided injections, one into each buttock, over 1-2 minute(s) by intramuscular route every 14 days for 3 doses

• Inject 10 milliliters (500 mg) as 2 equally divided injections, one into each buttock, over 1-2 minute(s) by intramuscular route once a month

• Inject 10 milliliters (500 mg) as 2 equally divided injections, one in each buttock, over 1-2 minute(s) by intramuscular route once a month